ICD D56.1ORPHA:848

Beta-Thalassaemia

Beta-thalassaemia is an inherited blood disorder caused by mutations in the HBB gene that reduce or eliminate production of the beta-globin protein, leading to anaemia of varying severity. The severe form (thalassaemia major) requires lifelong blood transfusions. Gene therapies and gene editing approaches are transforming treatment options.

199
Articles
68
Trials
Updated
4 April 2026
Loading...

Common Questions

What is Beta-Thalassaemia?

Beta-thalassaemia is an inherited blood disorder caused by mutations in the HBB gene that reduce or eliminate production of the beta-globin protein, leading to anaemia of varying severity. The severe form (thalassaemia major) requires lifelong blood transfusions. Gene therapies and gene editing approaches are transforming treatment options.

How many clinical trials are available for Beta-Thalassaemia?

RareWays currently indexes 68 clinical trials for Beta-Thalassaemia, of which 13 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Beta-Thalassaemia come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Beta-Thalassaemia.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.